PH29985A - Substituted quinolines and medicinal use thereof - Google Patents
Substituted quinolines and medicinal use thereofInfo
- Publication number
- PH29985A PH29985A PH37861A PH37861A PH29985A PH 29985 A PH29985 A PH 29985A PH 37861 A PH37861 A PH 37861A PH 37861 A PH37861 A PH 37861A PH 29985 A PH29985 A PH 29985A
- Authority
- PH
- Philippines
- Prior art keywords
- stands
- pct
- carboxy
- bond
- stand
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Water Treatment By Sorption (AREA)
- Optical Transform (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Quinoline Compounds (AREA)
- Luminescent Compositions (AREA)
- Optical Head (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB878728051A GB8728051D0 (en) | 1987-12-01 | 1987-12-01 | Chemical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
PH29985A true PH29985A (en) | 1996-10-29 |
Family
ID=10627789
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH37861A PH29985A (en) | 1987-12-01 | 1988-11-25 | Substituted quinolines and medicinal use thereof |
Country Status (16)
Country | Link |
---|---|
US (1) | US5110819A (ko) |
EP (1) | EP0420844B1 (ko) |
JP (1) | JPH03501477A (ko) |
KR (1) | KR900700454A (ko) |
AT (1) | ATE110364T1 (ko) |
CA (1) | CA1336602C (ko) |
DE (1) | DE3851232T2 (ko) |
ES (1) | ES2011919A6 (ko) |
GB (1) | GB8728051D0 (ko) |
GR (1) | GR1000422B (ko) |
IE (1) | IE64473B1 (ko) |
NZ (1) | NZ227003A (ko) |
PH (1) | PH29985A (ko) |
PT (1) | PT89118B (ko) |
WO (1) | WO1989005294A1 (ko) |
ZA (1) | ZA888763B (ko) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4920132A (en) * | 1987-11-03 | 1990-04-24 | Rorer Pharmaceutical Corp. | Quinoline derivatives and use thereof as antagonists of leukotriene D4 |
GB8919504D0 (en) * | 1989-08-29 | 1989-10-11 | Leo Pharm Prod Ltd | Chemical compounds |
US5021576A (en) * | 1989-10-27 | 1991-06-04 | American Home Products Corporation | 2-Anilino phenylacetic acid derivatives |
US5281593A (en) * | 1990-07-31 | 1994-01-25 | Lilly Industries Limited | Certain indole derivatives useful as leukotriene antagonists |
AU654140B2 (en) * | 1990-07-31 | 1994-10-27 | Lilly Industries Limited | N-benzyl indoles, processes for their preparation or pharmaceutical compositions containing them |
WO1994014797A1 (en) * | 1992-12-23 | 1994-07-07 | Smithkline Beecham Corporation | Quinoline compounds and the treatment of leucotriene related diseases therewith |
US5486612A (en) * | 1993-12-14 | 1996-01-23 | Eli Lilly And Company | N-benzyl dihydroindole LTD4 antagonists |
GB9414590D0 (en) * | 1994-07-20 | 1994-09-07 | Leo Pharm Prod Ltd | Chemical compounds |
ES2103180B1 (es) * | 1994-08-01 | 1998-04-01 | Menarini Lab | Fenilacetamidas con accion antagonista de los leucotrienos. |
US5602110A (en) * | 1994-08-31 | 1997-02-11 | Case Western Reserve University | Method and composition for treating cystic fibrosis |
EP0725063A1 (de) * | 1995-02-01 | 1996-08-07 | Ciba-Geigy Ag | Chinolin-Derivate |
ES2117551B1 (es) * | 1995-12-29 | 1999-04-01 | Menarini Lab | Quinolinas naftalenicas con accion antagonista de los leucotrienos, procedimiento para su preparacion y utilizacion de las mismas. |
US5756518A (en) * | 1996-04-02 | 1998-05-26 | Kowa Co., Ltd. | Phenylene derivatives |
CN1195739C (zh) * | 1997-06-17 | 2005-04-06 | 科研制药株式会社 | 2-氨磺酰苯甲酸衍生物 |
US6376671B1 (en) | 1997-06-17 | 2002-04-23 | Kaken Pharmaceutical Co., Ltd. | 2-sulfamoylbenzoic acid derivatives |
JP2004137284A (ja) * | 1997-06-17 | 2004-05-13 | Kaken Pharmaceut Co Ltd | 2−スルファモイル安息香酸誘導体 |
DE69805033T2 (de) * | 1997-09-26 | 2002-11-14 | Kowa Co., Ltd. | Tetrazolderivate als LTD4 und H1 Antagonisten |
IL145923A0 (en) * | 1999-04-28 | 2002-07-25 | Aventis Pharma Gmbh | Tri-aryl acid derivatives as ppar receptor ligands |
WO2001066098A2 (en) * | 2000-03-09 | 2001-09-13 | Aventis Pharma Deutschland Gmbh | Therapeutic uses of ppar mediators |
TW200418825A (en) | 2002-12-16 | 2004-10-01 | Hoffmann La Roche | Novel (R)-and (S) enantiomers of thiophene hydroxamic acid derivatives |
WO2005087710A1 (ja) * | 2004-03-15 | 2005-09-22 | Takeda Pharmaceutical Company Limited | アミノフェニルプロパン酸誘導体 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4625034A (en) * | 1985-02-04 | 1986-11-25 | Usv Pharmaceutical Corp. | 1,2-Dihydro; 1,2,3,4-tetrahydro; 5,8 dihydro; and 5,6,7,8-tetrahydroquinoline derivatives |
IE58870B1 (en) * | 1985-03-08 | 1993-11-17 | Leo Pharm Prod Ltd | Pyridine derivatives |
US4839369A (en) * | 1985-04-16 | 1989-06-13 | Rorer Pharmaceutical Corporation | Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments |
DK282986A (da) * | 1985-06-18 | 1987-02-24 | Merck Frosst Canada Inc | Substitueret quinolin og farmaceutisk praeparat indeholdende en saadan forbindelse |
EP0219307A3 (en) * | 1985-10-16 | 1987-10-14 | Merck Frosst Canada Inc. | 2-substituted quinolines |
ATE68789T1 (de) * | 1985-10-16 | 1991-11-15 | Merck Frosst Canada Inc | 2-substituierte chinoline. |
US4904786A (en) * | 1986-01-27 | 1990-02-27 | American Home Products Corporation | Quinoline compounds as antiallergic and antiinflammatory agents |
GB2185741B (en) * | 1986-01-27 | 1989-10-25 | American Home Prod | Heterocyclic sulphonamides |
IE59889B1 (en) * | 1986-02-14 | 1994-04-20 | Merck Frosst Canada Inc | 2-substituted quinoline dioic acids |
EP0271287A3 (en) * | 1986-12-11 | 1990-06-13 | Merck Frosst Canada Inc. | Quinoline dioic acids and amides |
US4920132A (en) * | 1987-11-03 | 1990-04-24 | Rorer Pharmaceutical Corp. | Quinoline derivatives and use thereof as antagonists of leukotriene D4 |
DE3814504A1 (de) * | 1988-04-29 | 1989-11-09 | Bayer Ag | (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
-
1987
- 1987-12-01 GB GB878728051A patent/GB8728051D0/en active Pending
-
1988
- 1988-11-15 IE IE341988A patent/IE64473B1/en not_active IP Right Cessation
- 1988-11-17 US US07/476,403 patent/US5110819A/en not_active Expired - Fee Related
- 1988-11-17 EP EP89900021A patent/EP0420844B1/en not_active Expired - Lifetime
- 1988-11-17 JP JP1500028A patent/JPH03501477A/ja active Pending
- 1988-11-17 WO PCT/DK1988/000188 patent/WO1989005294A1/en active IP Right Grant
- 1988-11-17 DE DE3851232T patent/DE3851232T2/de not_active Expired - Fee Related
- 1988-11-17 AT AT89900021T patent/ATE110364T1/de not_active IP Right Cessation
- 1988-11-18 NZ NZ227003A patent/NZ227003A/xx unknown
- 1988-11-23 ZA ZA888763A patent/ZA888763B/xx unknown
- 1988-11-25 GR GR880100797A patent/GR1000422B/el unknown
- 1988-11-25 PH PH37861A patent/PH29985A/en unknown
- 1988-11-28 CA CA000584360A patent/CA1336602C/en not_active Expired - Fee Related
- 1988-11-30 ES ES8803652A patent/ES2011919A6/es not_active Expired - Lifetime
- 1988-11-30 PT PT89118A patent/PT89118B/pt not_active IP Right Cessation
-
1989
- 1989-07-22 KR KR1019890701385A patent/KR900700454A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ZA888763B (en) | 1989-07-26 |
CA1336602C (en) | 1995-08-08 |
DE3851232D1 (de) | 1994-09-29 |
NZ227003A (en) | 1991-11-26 |
PT89118B (pt) | 1993-04-30 |
JPH03501477A (ja) | 1991-04-04 |
KR900700454A (ko) | 1990-08-13 |
PT89118A (pt) | 1988-12-01 |
EP0420844B1 (en) | 1994-08-24 |
IE64473B1 (en) | 1995-08-09 |
ATE110364T1 (de) | 1994-09-15 |
GB8728051D0 (en) | 1988-01-06 |
WO1989005294A1 (en) | 1989-06-15 |
DE3851232T2 (de) | 1995-02-02 |
US5110819A (en) | 1992-05-05 |
IE883419L (en) | 1989-06-01 |
ES2011919A6 (es) | 1990-02-16 |
EP0420844A1 (en) | 1991-04-10 |
GR1000422B (el) | 1992-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH29985A (en) | Substituted quinolines and medicinal use thereof | |
ES2076935T3 (es) | Compuesto de pirazolopiridina y procedimientos para su preparacion. | |
MA26697A1 (fr) | Composes nouveaux inhibiteurs de gsk-3 et compositions pharmaceutiques les contenant | |
EA199900242A1 (ru) | Аралкил- и аралкилиден-гетероциклические лактамы и имиды | |
TR199900046T2 (xx) | Se�ici siklooksijenaz-2 inhibit�rleri olarak ikameli piridinler. | |
SE8600913L (sv) | Kemiska foreningar | |
DE3372707D1 (en) | Spiro-(4,(3+n))-2-aza-alkan-3-carboxylic-acid derivatives, process for their preparation,agents containing them and their use | |
NO913923D0 (no) | 17beta-substituerte-4-aza-5alfa-androstan-3-on-derivater ogfremgangsmaate ved fremstilling av disse | |
ATE152719T1 (de) | Chinolylbenzofuran derivate als leukotrien- antagonisten | |
BG100692A (en) | New heterocyclic compounds | |
HUP9902133A2 (hu) | Mikroszomális trigliceridtranszfer-proteint gátló aromás inhibitorok | |
ATE212026T1 (de) | Halo-substituierte protein kinase c inhibitoren | |
FI943931A0 (fi) | Indolijohdannaisia steroidi-5alfa-reduktaasin inhibiittoreina | |
ES512574A0 (es) | "procedimiento de preparacion de derivados carboxilato". | |
DE69315836D1 (de) | Pyrazolpyridine für die behandlung der anämie | |
DK0823909T3 (da) | Hidtil ukendte heterocykliske forbindelser | |
DK118390A (da) | Substituerede quinoliner | |
ES8604958A1 (es) | Un procedimiento de obtencion de imidazoquinolinas | |
DK449488D0 (da) | Disubstituerede tetrazol-forbindelser med leukotrien-antagonistvirkning, fremgangsmaade til fremstil ling heraf og middel til brug ved fremgangsmaaden | |
RO82161A (ro) | Procedeu pentru prepararea 2-(2-clor-4-ciclopropilfenilimino)-imidazolidinei |